Patent Yard Sign in
Expired Canadian patentCanada

2-4-(2,3-dihydro-2-oxo-1h-benzimidazol-1-yl)-1- piperidinyl or 1,2,3,6-tetrahydro-1- pyridinyl))alkyl-1h-benzdeisoquinoline-1, 3(2h)-diones

CA 1088540 A · Owner: E. R. Squibb & Sons, Inc. · Inventors: Vogt, Berthold R.; Wade, Peter C.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

New compounds which exhibit antidepressant activity and are also useful as antiinflammatory agents have, the following formula, wherein R1 and R2 are independently selected from hydrogen halogen, lower alkyl, lower alkoxy, lower alkylthio nitro, amino, trifluoromethyl and cyano: R3 is hydrogen or lower alky; R4 and R5 are independently selected from hydrogen lower alkyl, lower alkoxy and halogen; A is straight or branched chain alkylene of 1 to 8 carbons; the dashed line indicates the optional presence of a double bond; and a pharmaceutically acceptable acid addition salt thereof.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted October 28, 1980. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended October 28, 1997.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 3, 1976
GrantedOctober 28, 1980
Term endedOctober 28, 1997
Patent numberCA 1088540 A
Classification (IPC)C07D221/14 +1 more

Timeline

Timeline From CIPO dates

1977198019831986198919921995Application filedMay 3, 1976Patent grantedOct 28, 1980Term endedOct 28, 1997

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.